FDA Takes Steps to Boost Generic Competition, Limit Prices - KTVN Channel 2 - Reno Tahoe Sparks News, Weather, Video

FDA Takes Steps to Boost Generic Competition, Limit Prices

Posted: Updated:

The Food and Drug Administration said it's taking steps to boost the number of generic prescription drugs on the market in an effort to make medicines more affordable and to prevent price gouging.

Copycat pills generally have been much cheaper than original brand-name drugs. But recent high-profile cases have shown how lack of competition and medicine shortages allowed several drug companies to drastically increase prices for generics and some older brand-name products such as EpiPen emergency allergy injectors.

New FDA commissioner Dr. Scott Gottlieb made addressing prices a priority, saying that agency can help by increasing market competition. While the FDA reviews and approves medications, it doesn't have the power to regulate prices.

"No patient should be priced out of the medicines they need, and as an agency dedicated to promoting public health, we must do our part to help patients get access to the treatments they require," Gottlieb said in a statement.

On Tuesday, the FDA said it will now give priority reviews to new generic drugs until there are at least three on the market. That's the level at which prices tend to drop sharply, up to 85% off the brand-name price.

The agency also published its first list of brand-name drugs that no longer have a patent's protection but don't yet have generic competition, a strategy to entice generic drugmakers to develop copycats.

The list includes an HIV medicine, a genetically engineered heart drug, prescription multivitamins and IV salt and sugar solutions. Some have been in short supply, sometimes for years, after quality problems shut down manufacturing lines or companies stopped making them to pursue more profitable products.

Among the best-known cases of dramatic price hikes: Mylan's fivefold increase for EpiPen's price and former pharmaceutical executive Martin Shkreli's Turing Pharmaceuticals raising the price of an old drug for a deadly infection more than 5,000%, to $750 per pill.

Meanwhile, the FDA has scheduled a July 18 meeting to discuss possible changes to its rules for approving generics, which inadvertently have enabled some makers of brand-name medicines to prevent or delay generic rivals.

(Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

  • Kristen Remington's Health Watch ReportsMore>>

  • Painting without Pain: Medtronic Drug Pump

    Wednesday, August 16 2017 9:15 PM EDT2017-08-17 01:15:05 GMT

    A man born with cerebral palsy had a tough go for many years. He lived in constant pain - up until fairly recently. Find out what changed and why his world is now more colorful than ever before in Health Watch.

    More >>

    A man born with cerebral palsy had a tough go for many years. He lived in constant pain - up until fairly recently. Find out what changed and why his world is now more colorful than ever before in Health Watch.

    More >>
  • Ask the Doctor: Shoulder Pain

    Ask the Doctor: Shoulder Pain

    Monday, August 14 2017 5:31 PM EDT2017-08-14 21:31:52 GMT

    Not all shoulder pain is the same. So, how do you know if you're a candidate for surgery? We're talking about the options in tonight's Ask the Doctor segment.

    More >>

    Not all shoulder pain is the same. So, how do you know if you're a candidate for surgery? We're talking about the options in tonight's Ask the Doctor segment.

    More >>
  • Senator Cortez Masto Visits Opioid Treatment Center

    Senator Cortez Masto Visits Opioid Treatment Center

    Friday, August 11 2017 8:33 PM EDT2017-08-12 00:33:47 GMT

    Nevada Senator Catherine Cortez Masto visited the Crossroads housing program's main campus on Friday. Her visit comes one day after President Trump called the opioid crisis an emergency.

    More >>

    Nevada Senator Catherine Cortez Masto visited the Crossroads housing program's main campus on Friday. Her visit comes one day after President Trump called the opioid crisis an emergency.

    More >>
Powered by Frankly
All content © Copyright 2000 - 2017 Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.